business / news / / Seeking Alpha
The firm now forecasts that 19M patients in Newsletters for Every Investor.
Morgan Stanley forecasts GLP-1 usage will reach 15% of the U.S. population.
KEY POINTS
- Oral GLP-1 formulations are expected to significantly expand the potential user base.
- Expanded access to GLP-1 drugs is projected to accelerate adoption rates in coming years.
- The report estimates 19 million U.S. patients will use GLP-1 medications in the near future.
COMPANIES
Summarized by Newsio from Seeking Alpha. How we summarize →